Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finn

Showing results (361-370 of 527) with videos related to

Pageof 53
Sort By:
The Journal of Infectious Diseases|September 9, 2000
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki diseaseA H Rowley, S T Shulman, C A Mask, et al.
Molecular Cancer Therapeutics|February 12, 2013
Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancerZev A Wainberg, Adrian Anghel, Amy M Rogers, et al.
Developmental Cognitive Neuroscience|April 6, 2019
Associations between cortical thickness and reasoning differ by socioeconomic status in developmentJulia A Leonard, Rachel R Romeo, Anne T Park, et al.
Cancer Treatment Reviews|August 31, 2025
Interpreting immunogenicity in oncology clinical trialsPeter R Galle, Martin Reck, David J Pinato, et al.
The American Journal of Surgical Pathology|December 23, 2004
Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entityD Ashley Hill, Paul E Swanson, Keith Anderson, et al.
Cold Spring Harbor Molecular Case Studies|December 10, 2021
Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in <i>PIK3CA</i>Sarah E Sheppard, Victoria R Sanders, Abhay Srinivasan, et al.
Liver Cancer|March 6, 2023
Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus BevacizumabChiun Hsu, Michel Ducreux, Andrew X Zhu, et al.
The Oncologist|October 3, 2022
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2Richard S Finn, Thomas Yau, Chih-Hung Hsu, et al.
British Journal of Cancer|October 29, 2009
Activity of the multikinase inhibitor dasatinib against ovarian cancer cellsG E Konecny, R Glas, J Dering, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Pageof 53

Showing results (361-370 of 527) with videos related to

Sort By:
Pageof 53
The Journal of Infectious Diseases|September 9, 2000
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki diseaseA H Rowley, S T Shulman, C A Mask, et al.
Molecular Cancer Therapeutics|February 12, 2013
Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancerZev A Wainberg, Adrian Anghel, Amy M Rogers, et al.
Developmental Cognitive Neuroscience|April 6, 2019
Associations between cortical thickness and reasoning differ by socioeconomic status in developmentJulia A Leonard, Rachel R Romeo, Anne T Park, et al.
Cancer Treatment Reviews|August 31, 2025
Interpreting immunogenicity in oncology clinical trialsPeter R Galle, Martin Reck, David J Pinato, et al.
The American Journal of Surgical Pathology|December 23, 2004
Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entityD Ashley Hill, Paul E Swanson, Keith Anderson, et al.
Cold Spring Harbor Molecular Case Studies|December 10, 2021
Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in <i>PIK3CA</i>Sarah E Sheppard, Victoria R Sanders, Abhay Srinivasan, et al.
Liver Cancer|March 6, 2023
Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus BevacizumabChiun Hsu, Michel Ducreux, Andrew X Zhu, et al.
The Oncologist|October 3, 2022
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2Richard S Finn, Thomas Yau, Chih-Hung Hsu, et al.
British Journal of Cancer|October 29, 2009
Activity of the multikinase inhibitor dasatinib against ovarian cancer cellsG E Konecny, R Glas, J Dering, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
Pageof 53